论文部分内容阅读
我院从１９９４年到１９９５年１２月，用ＰＣＭＦ和ＣＡＦ联合化疗方案治疗晚期乳腺癌４８例，效果满意。ＰＣＭＦ方案的有效率为６６．７％（１６／２４），其中ＣＲ为２９．２％（７／２４），ＰＲ为３７．５％（９／２４）。ＣＡＦ方案的有效率为５８．３％（１４／２４），其中ＣＲ为２０．８％（５／２４），ＰＲ为３７．５％（９／２４）。两种方案疗效无显著差别（Ｐ＞０．０５）。中位缓解期分别为７和８个月，两种方案相近。
In our hospital from 1994 to December 1995, 48 patients with advanced breast cancer were treated with the PCMF and CAF combined chemotherapy regimens with satisfactory results. The effective rate of the PCMF program was 66.7% (16/24), of which CR was 29.2% (7/24) and PR was 37.5% (9/24). The effective rate of the CAF program was 58.3% (14/24), of which CR was 20.8% (5/24) and PR was 37.5% (9/24). There was no significant difference in efficacy between the two regimens (P>0.05). The median remission period was 7 and 8 months respectively, and the two schemes were similar.